![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 23, 20979-20990, June 7, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The aberrant metabolism of
Amyloid Precursor Protein Family-induced Neuronal
Death Is Mediated by Impairment of the Neuroprotective
Calcium/Calmodulin Protein Kinase IV-dependent
Signaling Pathway*
,
,
Université Louis Pasteur,
Faculté de Médecine, EA 3433 Molecular signaling and
neurodegeneration, 67000 Strasbourg, France, the
§ Department of Neurodegenerative Disease Group, Aventis
Pharma, 94400 Vitry-sur Seine, France, and the ¶ Department
of Neurochemistry, Max-Planck Institute for Brain Research,
D-60528 Frankfurt, Germany
-amyloid
precursor protein (APP) and the progressive deposition of its derived
fragment
-amyloid peptide are early and constant pathological
hallmarks of Alzheimer's disease. Because APP is able to
function as a cell surface receptor, we investigated here whether a
disruption of the normal function of APP may contribute to the
pathogenic mechanisms in Alzheimer's disease. To this aim, we
generated a specific chicken polyclonal antibody directed against the
extracellular domain of APP, which is common with the
-amyloid
precursor-like protein type 2. Exposure of cultured cortical neurons to
this antibody (APP-Ab) induced cell death preceded by neurite
degeneration, oxidative stress, and nuclear condensation.
Interestingly, caspase-3-like protease was not activated in this
neurotoxic action suggesting a different mode of cell death than
classical apoptosis. Further analysis of the molecular mechanisms
revealed a calpain- and calcineurin-dependent proteolysis
of the neuroprotective calcium/calmodulin-dependent protein
kinase IV and its nuclear target protein cAMP responsive element
binding protein. These effects were abolished by the G protein
inhibitor pertussis toxin, strongly suggesting that APP binding
operates via a GTPase-dependent pathway to cause neuronal death.
*
This work was supported by the Réseau de Recherche
Alzheimer (Aventis Pharma).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed:
Université Louis Pasteur, Faculté de Médecine, EA
3433, Molecular signaling and neurodegeneration, 11 rue Humann, 67000 Strasbourg, France. Tel.: 33-3-90-24-30-91; Fax:
33-3-90-24-30-65; E-mail:
loeffler@neurochem.u-strasbg.fr.
This article has been cited by other articles:
![]() |
Y. Hashimoto, T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, et al. The Cytoplasmic Domain of Alzheimer's Amyloid-{beta} Protein Precursor Causes Sustained Apoptosis Signal-Regulating Kinase 1/c-Jun NH2-Terminal Kinase-Mediated Neurotoxic Signal via Dimerization J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 889 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Dahlgren, A. M. Manelli, W. B. Stine Jr., L. K. Baker, G. A. Krafft, and M. J. LaDu Oligomeric and Fibrillar Species of Amyloid-beta Peptides Differentially Affect Neuronal Viability J. Biol. Chem., August 23, 2002; 277(35): 32046 - 32053. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |